. There was a 1% fall in overall renal transplant numbers in 2015, with a fall in kidney donation from donors after brainstem death (6%) and from living donors (5%). . In 2015, death-censored renal transplant failure rates in prevalent patients were similar to previous years at 2.7% per annum. Transplant patient death rates were similar at 2.5 per 100 patient years. . The median age of incident and prevalent renal transplant patients in the UK was 50.9 and 53.8 years respectively.
. The median eGFR of prevalent renal transplant recipients was 51. 
Introduction
This chapter includes independent analyses regarding renal transplant activity and survival data from the UK Transplant Registry, held by the Organ Donation and Transplantation Directorate (ODT) of NHS Blood and Transplant (NHSBT). The UK Renal Registry (UKRR) has performed additional analyses of renal transplant recipient follow-up data examining demographics, clinical and biochemical variables. NHSBT records all information regarding the episode of transplantation (donor and recipient details) and the UKRR holds additional information on key clinical and biochemical variables in renal transplant recipients. The co-operation between these two organisations results in a comprehensive database describing the clinical care delivered to renal transplant patients within the UK. This allows for the comparison of key quality measures between centres and provides insight into the processes involved in the care of such patients in the UK.
This chapter is divided into six sections: (1) transplant activity, waiting list and survival data; (2) transplant demographics; (3) clinical and laboratory outcomes; (4) analysis of prevalent patients by chronic kidney disease (CKD) stage; (5) eGFR slope analysis; and (6) cause of death in transplant recipients. Methodology, results and a discussion of these analyses are provided in detail for all six sections separately.
The UK Renal Registry methodology has previously been described [1] . The UKRR collects quarterly clinical data via an electronic data extraction process from hospital based renal IT systems on all patients receiving renal replacement therapy. Throughout the chapter, the number preceding the centre name in each figure indicates the percentage of missing data for that centre for that variable.
Unless otherwise specified, prevalent transplant patients were defined as patients with a functioning renal transplant on the 31st December 2015.
A list of the Renal Association recommended audit measures which are relevant to the transplant population are given in appendix 1 of this chapter. Several of the audit measures are not currently reported by the UKRR in the annual report; the reasons behind this are varied, but predominantly relate to a high proportion of incomplete data or that the relevant variable is not currently within the specified UKRR dataset. Over time it is hoped to work with the renal community to improve reporting across the range of recommended standards.
Transplant activity, waiting list activity and survival data Introduction NHSBT prospectively collects donor and recipient data at the time of transplantation. They also request that transplant centres provide an annual paper based data return on the status of the recipient including graft function. This enables ODT to generate comprehensive analyses of renal transplant activity and graft survival statistics.
NHSBT attributes a patient to the centre that performed the transplant operation irrespective of where the patient was cared for before or after the procedure and hence only reports on transplant centre performance.
Methods
In 2015, there were 23 UK adult renal transplant centres, 19 in England, two in Scotland and one each in Northern Ireland and Wales.
Annual organ-specific updates and five-year reports with comprehensive data concerning the number of patients on the transplant waiting list, percentage of pre-emptive listing, the number of transplants performed, the number of deceased kidney donors (donor after brainstem death and donor after circulatory death), living kidney donors, patient survival and graft survival are available on the NHSBT website (https://www.organdonation.nhs.uk/ statistics/) Results During 2015, 3,174 kidney or kidney plus transplants were performed (table 3.1). The absolute number of living kidney donors showed a small decline in 2015, but still represented 32.9% of all transplants performed. Compared to the relative fall observed in 2014, there was recovery in the number of donor after circulatory death (DCD) transplants (+12%), whereas the number of deceased brainstem death donors did not increase. The number of kidney plus other organ transplants has not changed.
There were small differences in one-and five-year risk adjusted patient and graft survival rates amongst UK kidney transplant centres (table 3.2). These graft survival rates include grafts with primary non-function, which are excluded from analysis by some registries.
Using data from the UKRR on prevalent renal transplant patients on 1st January 2015, the death rate during 2015 was 2.5 per 100 patient years (CI 2.3-2.7) when censored for return to dialysis, and 2.7 per 100 patient years (CI 2.5-2.9) without censoring for dialysis. These death rates were similar to those observed over the last five years and have not shown any impact from the increasing age or comorbidity of the transplanted cohort. B QEH  92  97  83  90  96  99  93  95  Belfast  98  92  91  87  96  100  93  100  Bristol  94  94  83  87  97  100  96  95  Camb  94  96  85  90  99  99  97  96  Cardff  96  96  88  89  96  99  86  97  Covnt  89  92  87  86  99  100  90  96  Edin  95  97  82  85  95  99  89  93  Glasgw  93  96  90  90  95  99  94  95  L Barts  89  90  86  85  95  99  92  94  L Guys  93  98  85  90  98  99  93  96  L Rfree  93  96  90  93  98  100  98  98  L St.G  94  97  89  95  98  99  93  95  L West  96  98  85  92  96  99  87  96  Leeds  94  97  86  88  95  99  90  96  Leic  93  99  83  81  97  97  91  96  Liv Roy  91  93  87  88  97  98  85  95  MR I  9 6  9 6  8 9  9 0  9 9  9 8  9 6  9 5  Newc  95  96  82  86  99  100  93  95  Nottm  96  97  82  81  100  100  92  94  Oxford  93  96  89  90  96  99  96  93  Plymth  87  94  85  90  97  100  89  96  Ports  95  94  84  86  100  99  88  93  Sheff  95  94  85  94  99  100  96  98   All centres  94  96  86  89  97  99  92 During 2015, 2.7% of prevalent transplant patients experienced graft failure (excluding death as a cause of graft failure), which was a slight increase on the rate in 2014 (2.4%), and above the mean rate for 2009-2014 (2.5%).
Discussion
During 2015, there was a 1% reduction in overall kidney transplant numbers, with a fall in the number of living kidney donors. The number of deceased donor transplants remained stable, whilst there was an increase in deceased cardiac death kidney transplants compared to 2014. The graft failure rate of 2.7% per annum and the patient death rate of 2.5 per 100 patient years are similar to previous years, despite the changes in donor and recipient populations.
Transplant demographics

Introduction
Since 2008, all UK renal centres have established electronic linkage to the UKRR or Scottish Renal Registry, giving the UKRR complete coverage of individual patient level data across the UK.
The following sections should be interpreted in the context of centre-specific variations in repatriation policies; some transplant centres continue to follow up and report on all patients they transplant, whereas others refer patients back to non-transplanting centres at some point post-transplant. Some transplant centres only refer back patients when their graft is failing. The time post-transplantation that a patient is referred back to their local centre varies between transplant centres, but the UKRR can detect duplicate patients (being reported from both transplant and referring centres) and in such situations care is usually attributed to the referring centre (see appendix B for allocation procedure). This process may result in some discrepancies in transplant numbers particularly in Oxford/Reading and Clywd/Liverpool Royal.
Methods
Cambridge renal centre (Addenbrooke's) was unable to submit the 2015 data at patient level on time for the end of 2015 UKRR data collection. The centre was able to submit summary numbers of patients still on renal replacement therapy (RRT) at the end of 2015, by treatment modality, and incident numbers. Cambridge renal centre is therefore excluded from all centre level prevalent analysis. However their data have been included in the transplant rates calculation in England and UK, where only summary numbers are needed. For the calculation of transplant rates by Clinical Commissioning Groups (CCG) or Health Board/Social Care Areas (HB), where patient-level information are needed for age/gender standardisation, Cambridge data from 2014 were used instead, which will cause a slight underestimation of the rates. Those CCGs that are at least in part covered by Addenbrooke's were identified using 2014 data and they are flagged in table 3.4 (in CCGs where between 10-70% of the RRT population was seen in Addenbrooke's, rates are shown but the CCG is flagged, while for the two CCGs where most patients (.70%) are thought to be seen in Addenbrooke's, rates have been blanked as they would represent mainly 2014 data.
As Colchester did not have any transplant patients they were excluded from some of the analyses, though their dialysis patients were included in the relevant dialysis population denominators. Also, this year Bangor directly submitted its data on transplant patients (previously submitted mainly by Liverpool Royal) and it is therefore now included separately in centre analyses.
For the analysis of primary renal diagnosis (PRD) in transplant recipients, a few centres were excluded from some of the incidence years because of concerns relating to the reliability of PRD coding (with these centres submitting a high percentage of uncertain or missing aetiology codes).
Information on patient demographics (age, gender, ethnicity and PRD) for patients in a given renal centre was obtained from UKRR patient registration data fields. Individual patients were assigned to the centre that returned data for them during 2015. The prevalence of transplant patients in areas covered by individual CCG or HB was estimated based on the postcode of the registered address for patients on RRT. Data on ethnic origin, supplied as Patient Administration System (PAS) codes, were retrieved from fields within renal centre IT systems. For the purpose of this analysis, patients were grouped into White, South Asian, Black, Other and Unknown categories. The details of ethnicity regrouping into the above categories are provided in appendix H: Coding https://www.renalreg.org/publications-reports/.
Results and Discussion
Prevalent transplant numbers across the UK are described in table 3.3. Sharples/Casula/Byrne Sharples/Casula/Byrne The prevalence of renal transplant recipients in each CCG in England, Northern Ireland (Health and Social Care Trust Areas), Scotland (Health Boards) and Wales (Local Health Boards) and the proportion of prevalent patients according to modality in the renal centres across the UK are described in tables 3.4 and 3.5 respectively.
After standardisation for age and gender, unexplained variability was evident in the prevalence of renal transplant recipients, with some areas having higher than the predicted number of prevalent transplant patients per million population and others lower. There are a number of potential explanations for these inconsistencies, including geographical differences in access to renal transplantation in the UK. This has previously been analysed in detail by the UKRR [2] and is currently the focus of a large national study (access to Transplant and Transplant Outcome Measures (ATTOM)) [3] .
The proportion of prevalent RRT patients with a transplant relative to the number on dialysis has gradually risen over the last decade.
Age and gender
The gender ratio amongst incident and prevalent kidney transplant patients has remained stable for at least the last ten years (table 3.6, figure 3.1). The median age of incident transplant recipients has increased during the same time period, which reflects changes to the renal replacement therapy population. This is mirrored by an increase in the median age of the prevalent population, which reflects the increase in age at which patients are transplanted, the increase access to transplantation for older recipients, as well as improved survival after kidney transplantation over the last 10 years.
Primary renal diagnosis
The primary renal diagnosis of patients receiving a kidney transplant in the UK has remained relatively stable over the last five years (table 3.7).
Ethnicity
The ethnicity of those receiving a kidney transplant between 2010 and 2015 is shown in table 3.8. A comparison of the proportion of patients within each ethnic group receiving a transplant to those commencing dialysis from the same group is difficult because data on ethnicity were missing, or there was a high proportion with ethnicity classified as 'missing'. This is a particular issue in Scotland, where ethnicity reporting is not mandatory. Analysis isolated to the remainder of the Sharples/Casula/Byrne UK, where completeness of data was good, may allow assessment of variation in access to transplantation in future reports. There has been a year on year increase in the percentage of incident kidney recipients from non-White ethnic groups, which reflects the changing population of the UK, the different incidence of CKD in different groups and improved access to transplantation across these ethnic backgrounds.
Clinical and laboratory outcomes
Introduction There continued to be marked variation in the completeness of data (tables 3.9a, 3.9b) reported by each renal centre, particularly for blood pressure and parathyroid hormone, which limits the ability to perform more meaningful comparisons between centres, or determine the causes of inter-centre differences in outcomes. The 71 renal centres in the UK comprise 52 centres in England, five in Wales, five in Northern Ireland and nine in Scotland. Colchester was reported as having no transplanted patients and was therefore excluded. Cambridge was unable to submit patient level data for 2015. After exclusion of these centres, prevalent patient data from 69 renal centres across the UK were analysed.
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Methods
Data for key laboratory variables are reported for all prevalent patients with valid data returns for a given renal centre (both transplanting and non-transplanting centres) and for one year post-transplant results for patients transplanted 2008-2014, with patients attributed to the transplant centre that performed the procedure.
Time since transplantation may have a significant effect on key biochemical and clinical variables and this is likely to be independent of a centre's clinical practices. Therefore, inter-centre comparison of data on prevalent transplant patients is open to bias. To minimise bias relating to fluctuations in biochemical and clinical parameters occurring in the initial post-transplant period, one year post-transplantation outcomes are also reported. It is presumed that patient selection policies and local clinical practices are more likely to be relevant in influencing outcomes 12 months post-transplant and therefore comparison of outcomes between centres is more robust. However, even the 12 months posttransplant comparisons could be biased by the fact that in some centres, repatriation of patients only occurs if the graft is failing whereas in others it only occurs if the graft function is stable.
Centres with ,10 patients or ,50% data completeness have been excluded from the figures. Scottish centres were also excluded from blood pressure analyses as data were not provided.
Prevalent patient data
Biochemical and clinical data for patients with a functioning transplant followed in either a transplanting or non-transplanting centre were included in the analyses. The cohort consisted of prevalent patients as on 31st December 2015. Patients were considered as having a functioning transplant if 'transplant' was listed as the last mode of RRT in the last quarter of 2015. Patients were assigned to the renal centre that sent the data to the UKRR but some patients will have received care in more than one centre. If data for the same transplant patient were received from both the transplant centre and non-transplant centre, care was usually allocated to the non-transplant centre (see appendix B). Patients with a functioning transplant of less than three months duration were excluded from analyses. For haemoglobin, estimated glomerular filtration rate (eGFR), corrected calcium, phosphate and blood pressure (BP), the latest value in quarter 3 or quarter 4 of 2015 was used.
Estimated glomerular filtration rate (eGFR)
For the purpose of eGFR calculation, the original 4-variable MDRD formula was used (with a constant of 186) to calculate eGFR from the serum creatinine concentration as reported by the centre (unless otherwise stated). A wide variety of creatinine assays are in use in clinical biochemistry laboratories in the UK, and it is not possible to ensure that all measurements of creatinine concentration collected by the UKRR are harmonised. Patients with valid serum creatinine results but no ethnicity data were classed as White for the purpose of the eGFR calculation.
One year post-transplant data
Patients who received a renal transplant between 1st January 2008 and 31st December 2014 were assigned according to the renal centre in which they were transplanted. In a small number of instances, the first documented evidence of transplantation in a patient's record is from a timeline entry in data returned from a non-transplant centre, in these instances the patient was reassigned to the nearest transplant centre.
As this analysis is stratified by transplant type, and for some of the renal centres reporting of donor type to the UKRR is poor, donor-type used in this analysis was obtained from NHSBT.
Patients who had died or experienced graft failure within 12 months of transplantation were excluded from the analyses. Patients with more than one transplant during 2008-2014 were included as separate episodes provided each of the transplants functioned for a year. For each patient, the most recent laboratory or blood pressure result for the relevant 4th/5th quarter after renal transplantation was taken to be representative of the one year post-transplant outcome. Again, for the purpose of the eGFR calculation patients with valid serum creatinine results but missing ethnicity data were classed as White.
Results and Discussion
Post-transplant eGFR in prevalent transplant patients When interpreting eGFR post-transplantation, it is important to remember that estimated GFR formulae only have a modest predictive performance in the transplant population [4] . Median eGFR in each centre and percentage of patients with eGFR ,30 ml/min/1.73 m 2 are shown in figures 3.2 and 3.3.
The median eGFR was 51.8 ml/min/1.73 m 2 , with 13.3% of prevalent transplant recipients having an eGFR ,30 ml/min/1.73 m 2 , summarised by centre in table 3.10. Whilst local repatriation policies on timing of transfer of care for patients with failing transplants from transplant centres to referring centres might explain some of the differences, it is notable that both transplanting and non-transplanting centres feature at both ends of the scale in figure 3 .3. The accuracy of the 4-variable MDRD equation in estimating GFR 560 ml/min/ 1.73 m 2 is questionable [5] , therefore a figure describing this is not included in this chapter. Graft function at one year post-transplantation may predict subsequent long-term graft outcome [6] . Figures 3.5a, 3 .5b, and 3.5c show the median one-year post-transplant eGFR for patients transplanted between 2008-2014, by transplant type. Living kidney donation had the highest median eGFR at one year (57.5 ml/min/ 1.73 m 2 ), followed by donation after brainstem death (53.7 ml/min/1.73 m 2 ) and donation after circulatory death (50.4 ml/min/1.73 m 2 ). Figures 3.6a, 3 .6b and 3.6c show one-year posttransplant eGFR by donor type and year of transplantation. There was no trend in eGFR over the time period for live kidney donation transplantation, donation after brainstem death or donation after circulatory death.
Haemoglobin in prevalent transplant patients
The Renal Association Anaemia guidelines recommend 'achieving a population distribution centred on a mean of 11 g/dl with a range of 10-12 g/dl ' [7] (equivalent to 110 g/L, range 100-120 g/L). However, many transplant patients with good transplant function will have haemoglobin concentrations .120 g/L without the use of erythropoiesis stimulating agents, and so it is inappropriate to audit performance using the higher limit.
A number of factors, including comorbidity, immunosuppressive medication, graft function, ACE inhibitor use, erythropoietin (EPO) use, intravenous or oral iron use, that affect centre-specific protocols for management of anaemia will affect haemoglobin concentrations in transplant patients. Most of these data are not collected by the UKRR and therefore caution must be used when interpreting analyses of haemoglobin attainment.
Figures 3.7a and 3.7b report centre results stratified according to graft function as estimated by eGFR. The percentage of prevalent transplant patients achieving Hb 5100 g/L in each centre, stratified by eGFR, is displayed in figures 3.8a and 3.8b. Figure 3 .9 describes the percentage of prevalent patients by centre with haemoglobin ,100 g/L as a funnel plot enabling more reliable comparison of outcomes between centres across the UK. With 69 centres included and a normal distribution, 3-4 centres would be expected to fall between the 95%-99.9% CI (1 in 20) and no centres should fall outside the 99.9% CI purely as a chance event.
One centre (London St Bartholomew's) fell outside the upper 99.9% CI and two further centres (London Guys and London Kings) fell outside the upper 95% CI indicating a higher than predicted proportion of transplant patients not achieving the haemoglobin target. Seven centres fell outside the lower 99.9% CI, indicating they performed better than expected with fewer than predicted patients having a haemoglobin ,100 g/L.
Blood pressure in prevalent transplant patients
The UK Renal Association (RA) guideline for the care of kidney transplant recipients recommends that 'Blood pressure should be <130/80 mmHg (or <125/ 75 mmHg if proteinuria)' [8] . This blood pressure (BP) target is the same as that used in previous annual reports. Completeness for blood pressure data returns was variable with some centres unable to report. Data from 34 centres with .50% data returns were included in the analysis. Despite this restriction, caution needs to be exercised in interpretation of these results because of the volume of missing data and potential bias, (e.g. a centre may be more likely to record and report blood pressure data electronically in patients with poor BP control). 
Analysis of prevalent patients by CKD stage
Introduction Approximately 2.7% of prevalent transplant patients returned to dialysis in 2015, a similar percentage to that seen over the last few years. Amongst patients with native chronic kidney disease, late presentation is associated with poor outcomes, largely attributable to lack of specialist management of anaemia, acidosis, hyperphosphataemia and to inadequate advance preparation for dialysis. Transplant recipients on the other hand, are almost always followed up regularly in specialist transplant or renal clinics and it would be reasonable to expect patients with failing grafts to receive appropriate care and therefore have many of their modifiable risk factors addressed before complete graft failure and return to dialysis.
Methods
The transplant cohort consisted of prevalent transplant recipients as on 31st December 2015 and patients were classified according to the KDIGO staging criteria with the suffix of 'T' to represent their transplant status. Patients with missing ethnicity information were classified as White for the purpose of calculating eGFR. Prevalent dialysis patients, except those who commenced dialysis Only patients on peritoneal dialysis were considered when examining differences in serum phosphate between transplant recipients and dialysis patients. For both the transplant and dialysis cohorts, the analysis used the most recent available value from the last two quarters of the 2015 laboratory data. Scottish centres were excluded from blood pressure, cholesterol and PTH analyses as corresponding data were not provided. Table 3 .11 shows that 13.3% of the prevalent transplant population (3, achieved UK Renal Association standards for some key biochemical and clinical outcome variables less often than dialysis patients. This substantial group of patients continues to represent a challenge, and improved predialysis management should allow for timely re-listing for transplantation if appropriate, and a smooth transition to another renal replacement modality.
Results and Discussion
eGFR slope analysis
Introduction
The gradient of deterioration in eGFR (slope) may predict patients likely to have early graft failure. The eGFR slope and its relationship to specific patient characteristics are presented here. 
Methods
All UK patients aged 518 years receiving their first renal transplant between 1st January 2004 and 31st December 2013, were considered for inclusion. A minimum duration of 18 months graft function was required and three or more creatinine measurements from the second year of graft function onwards were used to plot eGFR slope. If a transplant failed but there were at least three creatinine measurements between one year post-transplant and graft failure, the patient was included but no creatinine measurements after the quarter preceding the recorded date of transplant failure were analysed.
Slopes were calculated using linear regression, assuming linearity, and the effect of age, ethnicity, gender, diabetes, donor type, year of transplant and current transplant status were analysed. P values were calculated using the Kruskal-Wallis test. eGFR was calculated using the CKD-EPI equation and results expressed as ml/min/1.73 m 2 /year. The CKD-EPI equation was used in preference to the MDRD formula as it is thought to have a greater degree of accuracy at higher levels of eGFR [9] .
Results and Discussion
The study cohort consisted of 17,357 patients. The median GFR slope was −0.56 ml/min/1.73 m 2 /year (table 3.12). The gradient was steeper for Black recipients (−1.01 ml/min/1.73 m 2 /year), in keeping with previously published data suggesting poorer outcomes for this group [10] .
There was no statistically significant difference in eGFR slope in recipients of deceased donor kidneys (−0.57 ml/min/1.73 m 2 /year) compared to patients who received organs from live donors (−0.54 ml/min/ 1.73 m 2 /year), although there was a significant difference in the eGFR slope in recipients of deceased cardiac death kidneys (−0.33 ml/min/1.73 m /year). The slope was steeper in younger recipients, possibly reflecting differences in causes of graft failure. As might be expected, the steepest slope was in patients where the transplant subsequently failed. This analysis has assumed linearity of progression of fall in GFR and further work is ongoing to characterise the patterns of progression more precisely.
Cause of death in transplant recipients
Introduction Differences in causes of death between dialysis and transplant patients may be expected due to selection for transplantation and use of immunosuppression. Chapter 5 includes a more detailed discussion on cause of death in dialysis patients.
Methods
The cause of death is sent by renal centres as an ERA-EDTA registry code. These have been grouped into the following categories: cardiac disease, cerebrovascular disease, infection, malignancy, treatment withdrawal, other and uncertain.
Some centres have high data returns to the UKRR regarding cause of death, whilst others return no information. Provision of this information is not mandatory. Analysis of prevalent patients included all those aged over 18 years and receiving RRT on 1st January 2015. Table 3 .13 and figure 3 .11 show the differences in the cause of death between prevalent dialysis and transplant patients. Table 3 .14 shows the cause of death for prevalent transplant patients by age.
Results and Discussion
Death due to cardiovascular disease was less common in transplanted patients than in dialysis patients, perhaps reflecting the lower age of the transplanted patients, and cardiovascular screening undertaken during transplant work-up; transplant recipients are a pre-selected lower 
